MyAverix Finance
US · Healthcare
Dyne Therapeutics Inc (DYN)
Biotechnology
Dyne Therapeutics Inc (DYN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DYN
Dyne Therapeutics Inc (DYN) — FAQ
What is DYN's P/E ratio?
The price-to-earnings (P/E) ratio for Dyne Therapeutics Inc (DYN) is 18.00 (data as of 2026-03-24).
Does Dyne Therapeutics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Dyne Therapeutics Inc (DYN). Check the MyAverix Finance app for the latest dividend data.
What sector is Dyne Therapeutics Inc in?
Dyne Therapeutics Inc (DYN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is DYN listed on?
DYN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.